Sakar Healthcare — 360° view

Sakar Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹87 crore and net profit of ₹11 crore for the September 2026 quarter.

Sakar Healthcare (NSE: SAKAR) closed at ₹1,023.40 on 20 Nov 2026, up 161.4% over the past year. Its market capitalisation is ₹2,277 crore and it trades at 53.1 times earnings.

Share price
₹1,023.40 (20 Nov 2026)
Market cap
₹2,277 Cr (20 Nov 2026)
P/E
53.12 (20 Nov 2026)
Revenue
₹87 Cr (September 2026 quarter)
Net profit
₹11 Cr (September 2026 quarter)
ROCE
12.4% (FY26)
ROE
9.99% (FY26)
Book value
₹156 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,229.85 / ₹352.50 (20 Nov 2026)
1-year return
161.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SAKAR

Incorporated in 2004, Sakar Healthcare Ltd is in the business of manufacturing Research & Development of Pharmaceutical products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.